Medtronic plc (LON:0Y6X)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of GBP 94.54 billion. The enterprise value is 110.20 billion.

Market Cap	94.54B
Enterprise Value	110.20B

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	Sep 26, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	87.36%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 26.40 and the forward PE ratio is 16.80.

PE Ratio	26.40
Forward PE	16.80
PS Ratio	3.62
PB Ratio	2.57
P/TBV Ratio	n/a
P/FCF Ratio	24.16
P/OCF Ratio	17.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.93, with an EV/FCF ratio of 28.16.

EV / Earnings	30.78
EV / Sales	4.24
EV / EBITDA	14.93
EV / EBIT	21.68
EV / FCF	28.16

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.60.

Current Ratio	2.42
Quick Ratio	1.48
Debt / Equity	0.60
Debt / EBITDA	2.95
Debt / FCF	5.59
Interest Coverage	9.57

Financial Efficiency

Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 5.48%.

Return on Equity (ROE)	9.82%
Return on Assets (ROA)	4.68%
Return on Invested Capital (ROIC)	5.48%
Return on Capital Employed (ROCE)	8.35%
Revenue Per Employee	274,998
Profits Per Employee	37,692
Employee Count	95,000
Asset Turnover	0.38
Inventory Turnover	2.06

Taxes

In the past 12 months, Medtronic has paid 680.97 million in taxes.

Income Tax	680.97M
Effective Tax Rate	15.90%

Stock Price Statistics

The stock price has increased by +22.99% in the last 52 weeks. The beta is 0.72, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+22.99%
50-Day Moving Average	97.23
200-Day Moving Average	91.20
Relative Strength Index (RSI)	49.61
Average Volume (20 Days)	6,923

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.69

Income Statement

In the last 12 months, Medtronic had revenue of GBP 26.12 billion and earned 3.58 billion in profits. Earnings per share was 2.77.

Revenue	26.12B
Gross Profit	17.13B
Operating Income	5.11B
Pretax Income	4.28B
Net Income	3.58B
EBITDA	7.20B
EBIT	5.11B
Earnings Per Share (EPS)	2.77

Balance Sheet

The company has 6.26 billion in cash and 21.87 billion in debt, giving a net cash position of -15.58 billion.

Cash & Cash Equivalents	6.26B
Total Debt	21.87B
Net Cash	-15.58B
Net Cash Per Share	n/a
Equity (Book Value)	36.72B
Book Value Per Share	28.52
Working Capital	10.57B

Cash Flow

In the last 12 months, operating cash flow was 5.35 billion and capital expenditures -1.43 billion, giving a free cash flow of 3.91 billion.

Operating Cash Flow	5.35B
Capital Expenditures	-1.43B
Free Cash Flow	3.91B
FCF Per Share	n/a

Margins

Gross margin is 65.58%, with operating and profit margins of 19.56% and 13.71%.

Gross Margin	65.58%
Operating Margin	19.56%
Pretax Margin	16.39%
Profit Margin	13.71%
EBITDA Margin	27.54%
EBIT Margin	19.56%
FCF Margin	14.98%

Dividends & Yields

This stock pays an annual dividend of 2.14, which amounts to a dividend yield of 2.17%.

Dividend Per Share	2.14
Dividend Yield	2.17%
Dividend Growth (YoY)	-0.83%
Years of Dividend Growth	n/a
Payout Ratio	75.86%
Buyback Yield	1.73%
Shareholder Yield	3.90%
Earnings Yield	3.79%
FCF Yield	4.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.91 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.91
Piotroski F-Score	7